Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Real-world evidence analysis of palbociclib prescribing patterns for patients with advanced/metastatic breast cancer treated in community oncology practice in the USA one year post approval

Fig. 2

Highest grade of neutropenia diagnosis (%) by number of cycles completed† among patients receiving treatment with palbociclib + letrozole. †Cycles approximated by time since initiation of palbociclib: cycles 1–2 = 1–56 days; cycles 1–4 = 1–112 days; cycles 1–6 = 1–168 days. ANC, absolute neutrophil count

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us